Pulmonary, Critical Care, Allergy and Sleep Medicine Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Medical Service, Veterans Affairs Health Care System, San Francisco, CA, United States.
Front Immunol. 2021 Oct 7;12:704172. doi: 10.3389/fimmu.2021.704172. eCollection 2021.
Advanced donor age is a risk factor for poor survival following lung transplantation. However, recent work identifying epigenetic determinants of aging has shown that biologic age may not always reflect chronologic age and that stressors can accelerate biologic aging. We hypothesized that lung allografts that experienced primary graft dysfunction (PGD), characterized by poor oxygenation in the first three post-transplant days, would have increased biologic age. We cultured airway epithelial cells isolated by transbronchial brush at 1-year bronchoscopies from 13 subjects with severe PGD and 15 controls matched on age and transplant indication. We measured epigenetic age using the Horvath epigenetic clock. Linear models were used to determine the association of airway epigenetic age with chronologic ages and PGD status, adjusted for recipient PGD risk factors. Survival models assessed the association with chronic lung allograft dysfunction (CLAD) or death. Distributions of promoter methylation within pathways were compared between groups. DNA methyltransferase (DNMT) activity was quantified in airway epithelial cells under hypoxic or normoxic conditions. Airway epigenetic age appeared younger but was strongly associated with the age of the allograft (slope 0.38 per year, 95% CI 0.27-0.48). There was no correlation between epigenetic age and recipient age (P = 0.96). Epigenetic age was 6.5 years greater (95% CI 1.7-11.2) in subjects who had experienced PGD, and this effect remained significant after adjusting for donor and recipient characteristics (P = 0.03). Epigenetic age was not associated with CLAD-free survival risk (P = 0.11). Analysis of differential methylation of promoters of key biologic pathways revealed hypomethylation in regions related to hypoxia, inflammation, and metabolism-associated pathways. Accordingly, airway epithelial cells cultured in hypoxic conditions showed suppressed DNMT activity. While airway methylation age was primarily determined by donor chronologic age, early injury in the form of PGD was associated with increased allograft epigenetic age. These data show how PGD might suppress key promoter methylation resulting in long-term impacts on the allograft.
高龄供体是肺移植后生存不良的一个危险因素。然而,最近确定衰老的表观遗传学决定因素的研究表明,生物年龄并不总是反映实际年龄,压力可以加速生物衰老。我们假设经历原发性移植物功能障碍(PGD)的肺同种异体移植物会有更高的生物年龄,PGD 的特征是移植后前 3 天氧合不良。我们在 1 年支气管镜检查时培养了 13 名严重 PGD 患者和 15 名按年龄和移植指征匹配的对照组经支气管镜刷检分离的气道上皮细胞。我们使用 Horvath 表观遗传时钟测量表观遗传年龄。线性模型用于确定气道表观遗传年龄与实际年龄和 PGD 状态的关联,调整了受者 PGD 危险因素。生存模型评估与慢性肺同种异体移植物功能障碍(CLAD)或死亡的关联。比较了两组之间途径内启动子甲基化的分布。在缺氧或常氧条件下定量测定气道上皮细胞中的 DNA 甲基转移酶(DNMT)活性。气道表观遗传年龄看起来更年轻,但与同种异体移植物的年龄密切相关(斜率为每年 0.38,95%CI 0.27-0.48)。表观遗传年龄与受者年龄无相关性(P = 0.96)。经历过 PGD 的患者的表观遗传年龄大 6.5 岁(95%CI 1.7-11.2),调整供者和受者特征后,这种影响仍然显著(P = 0.03)。表观遗传年龄与 CLAD 无生存风险无关(P = 0.11)。关键生物学途径启动子差异甲基化分析显示,与缺氧、炎症和代谢相关途径相关的区域出现低甲基化。因此,在缺氧条件下培养的气道上皮细胞显示出 DNMT 活性受到抑制。虽然气道甲基化年龄主要由供体实际年龄决定,但 PGD 形式的早期损伤与同种异体移植物的表观遗传年龄增加有关。这些数据表明 PGD 如何抑制关键启动子甲基化,从而对同种异体移植物产生长期影响。